Skip to main content

MoneyWorks4Me

Aayush Agrawal submits disclosure

15 Feb 2019 Evaluate

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aayush Agrawal.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1882.10
Dr. Reddys Labs. 1388.85
Cipla 1431.05
Lupin 1960.85
Zydus Lifesciences 1203.00
View more..